Pre-PMF
Before a repeatable sales motion exists. The founder is still testing who the buyer is and what they will pay for, so there is often not yet a system stable enough for the diagnostic to read.
Read the stage →The system that produced results at one growth stage becomes the constraint at the next. The dysfunction families stay the same, but which one carries the load changes as the company grows.
Five organisational contexts. The constraint moves as the company grows; each page reads which one is carrying the load.
Before a repeatable sales motion exists. The founder is still testing who the buyer is and what they will pay for, so there is often not yet a system stable enough for the diagnostic to read.
Read the stage →A repeatable motion exists, but it lives in the founder rather than in a system anyone else can run. The founder is usually still the best seller, and the cost is everything that does not happen because of that.
Read the stage →A single founder-led motion has to split into roles that can be repeated by people who did not invent it. What a small team handled through direct conversation does not survive role separation automatically.
Read the stage →A working commercial motion gets multiplied across new territories, segments or teams, and the operating model that carried the first one has to travel with it, not just the people.
Read the stage →The system is mature and the dysfunction is expensive precisely because it is stable. Nobody is in crisis, which is why the loss compounds quietly for years before anyone prices it.
Read the stage →Each stage is held together by a different mechanism. A transition is the handover between two of them, and the gap in that handover is where the strain shows up.
The six dysfunction families and the six financial-consequence components do not change between an early-stage team and an enterprise one. What changes is which family carries the load and how it disguises itself, which is why the stage alone cannot answer it in advance.
Growth stage explains which constraint is likely to be carrying the load. It does not decide whether a diagnosis can be defended.
Without repeated evidence there is no pattern to separate from an experiment, so Build fits before measurement.
Interviews, operating data and financial records decide what a finding can claim. Without them, nothing holds.
A sequenced roadmap needs someone able to change roles, handoffs and ownership behind it.
Not sure? Test the fit in one call →
Five sectors, five different disguises, whatever stage you sit at.
Compare industries →The six families, the signals that reveal them and how each one turns into cost.
Explore the Diagnosis →Ten questions, two minutes. A first read on which part of your system is carrying the most strain.
Take the Strain Check →Use 30 minutes to define the operating question, test what evidence exists and decide whether Kihon has a role at all. No scope is proposed before that is clear.
Discuss the operating problem